

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | €1.13 | €408.45 Free shipping | |
| 270 pills | €1.16 | €314.66 Free shipping | |
| 180 pills | €1.23 | €220.86 Free shipping | |
| 120 pills | €1.33 | €160.35 | |
| 90 pills | €1.45 | €130.09 | |
| 60 pills | €1.63 | €98.32 | |
| 30 pills | €2.27 | €68.06 | |
| 360 pills | €1.21 | €435.68 Free shipping | |
| 270 pills | €1.26 | €338.86 Free shipping | |
| 180 pills | €1.33 | €239.01 Free shipping | |
| 120 pills | €1.44 | €172.45 | |
| 90 pills | €1.54 | €139.17 | |
| 60 pills | €1.77 | €105.88 | |
| 30 pills | €2.42 | €72.60 |
This page provides general information about Provigil (modafinil). It is not a substitute for professional medical advice. For personalised guidance, please consult a pharmacist or a doctor in Ireland.
Narcolepsy and related sleep disorders are characterised by persistent daytime sleepiness and episodes of suddenly falling asleep. Narcolepsy is considered a neurological sleep disorder, and studies suggest that maintaining wakefulness can significantly improve daytime functioning and safety in daily activities.
Provigil contains the active ingredient modafinil, a wakefulness-promoting agent. It belongs to a class of medicines sometimes referred to as eugeroics, which are designed to help people stay alert during the day. The product is supplied as tablets for oral use and should be taken under medical supervision.
The primary purpose of Provigil is to increase wakefulness and reduce sleepiness in adults with certain sleep-related conditions. It does not cure the underlying disorder, and treatment is usually part of a broader plan that may include lifestyle changes and other therapies. In Ireland, Provigil may require a prescription depending on local rules; always follow the instructions provided by a prescriber and the official patient information leaflet.
When used appropriately, Provigil can help people remain awake during daytime activities, which may reduce episodes of sleepiness that could affect safety at work or while driving. A healthcare professional will determine whether Provigil is suitable based on medical history, current medications, and the specific sleep disorder being treated.
Provigil is indicated for excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. The aim is to improve daytime alertness and reduce sleepiness during waking hours. The treatment plan should address both symptoms and the overall management of the sleep disorder.
In narcolepsy, daytime sleepiness is a prominent symptom that can interfere with daily tasks and safety. Provigil may help individuals remain awake and responsive during the day, enabling improved participation in work, study, and daily routines. For obstructive sleep apnea/hypopnea syndrome, wakefulness-promoting therapy is used alongside other treatments such as continuous positive airway pressure (CPAP) to help sustain daytime function. In shift work sleep disorder, Provigil may reduce the strong tendency to doze during work shifts, supporting performance and safety.
Provigil is not a cure for these conditions and is not intended to treat other kinds of fatigue that are not caused by the conditions above. If symptoms persist or change, a clinician should reassess the treatment plan. If a diagnosis has not been established or if new symptoms arise, medical advice should be sought promptly.
All use should be guided by the official product information and by a healthcare professional. If there is any doubt about whether Provigil is appropriate, the reader is advised to consult the official leaflet or a pharmacist for guidance in the Irish healthcare setting.
The exact mechanism by which modafinil promotes wakefulness is not completely understood. It is considered to act on brain networks that regulate alertness and sleep, potentially influencing several neurotransmitter systems. The overall effect is increased wakefulness during the day, which can help reduce excessive daytime sleepiness.
Modafinil is thought to interact with parts of the brain involved in wake-promoting pathways, including the hypothalamus and related circuits. It may have modulatory effects on dopamine signaling and other neurochemical systems, but the precise sequence of events remains the subject of ongoing scientific investigation. The therapeutic outcome is improved morning-to-daytime alertness for the conditions described above.
Because the drug does not function as a typical stimulant, the profile of side effects and risks differs from older stimulant medications. The intent is to provide a sustained improvement in daytime wakefulness with a tolerable safety profile when used as prescribed. If there is uncertainty about how the drug works in a particular patient, consult the official leaflet or a pharmacist for clarification.
In all cases, Provigil should be used only as directed by a healthcare professional. If additional information is needed about the pharmacology or its implications for specific health conditions, a pharmacy team can provide patient-centred explanations based on local guidelines in Ireland.
The usual starting approach involves taking a single daily dose in the morning to support wakefulness during waking hours. The exact dose and any adjustments should be determined by a clinician who has considered the individual’s medical history and medications. Do not adjust the dose without professional guidance.
Provigil is taken orally as tablets. It may be taken with or without food. If a large or fatty meal is consumed close to the dosing time, a slight delay in absorption could occur; however, the effect on overall wakefulness is not typically dramatic. To minimise sleep interference, dosing is generally scheduled for the morning hours.
Consistency matters. If a dose is missed, it should be skipped and normal dosing resumed at the next scheduled time. Do not take a double dose to make up for a forgotten one. If a dose is missed and there is concern about daytime sleepiness, contact a clinician for advice. It is important to follow the prescriber’s directions and the information in the official leaflet, especially when other medicines are used concurrently.
Special populations, such as adolescents or older adults, may require different considerations. If there is any doubt about appropriate dosing in a given situation, a pharmacist or doctor should be consulted. Monitoring by a clinician helps ensure the balance between wakefulness benefits and potential adverse effects.
Provigil should not be used by individuals with a known hypersensitivity to modafinil or any component of the product. Allergic reactions to medicines containing modafinil or similar compounds can occur, and medical attention should be sought if signs of an allergic reaction develop.
In particular, severe skin reactions or anaphylaxis, though rare, require immediate medical attention. A clinician will assess risk factors and advise on alternatives if needed. The possibility of pregnancy or lactation, and other health circumstances, may influence suitability for Provigil; professional guidance is essential in these situations.
Provigil is generally not recommended for use in individuals under 18 years of age unless specifically advised by a clinician. If the patient is pregnant or breastfeeding, the risks and benefits should be discussed with a healthcare professional. A detailed review of medical history is necessary to determine suitability in each case.
Because dosing and risks depend on the overall health status, queries about contraindications should be addressed by a prescriber or a pharmacist familiar with Ireland’s regulatory framework. If any uncertainty arises, refer to the official leaflet and seek professional advice before starting treatment.
Potential cardiovascular effects, including changes in blood pressure or heart rate, may occur in some individuals. A baseline assessment of cardiovascular status is often useful, and monitoring during treatment helps identify any concerns early. Seek medical advice if chest pain, palpitations, or persistent headaches develop.
Mental health surveillance is advised during therapy. New or worsening anxiety, agitation, irritability, or mood changes may occur in some patients. If severe or persistent psychiatric symptoms appear, the prescriber may adjust therapy or discontinue Provigil as appropriate.
Insomnia is a possible consequence of daytime wakefulness promotion. To reduce sleep disruption, dosing is typically scheduled for the morning hours and avoided late in the day. If sleep difficulties arise, a clinician should be consulted to determine the best approach.
Provigil may interact with other medicines and substances. A full medication review should be conducted at the start of treatment and when new medicines are added. Inform a healthcare professional about all prescriptions, over-the-counter drugs, herbal products, and supplements to assess potential interactions. If unsure, seek guidance from a pharmacist before taking any new product.
Common adverse effects include headache, nausea, and dizziness. Some patients may experience dry mouth, nervousness, or trouble sleeping. These effects are typically mild to moderate and may lessen with continued use or dose adjustment under medical supervision.
Other possible side effects include diarrhoea, indigestion, or back pain. A small number of individuals may notice changes in appetite or mood. If any side effect becomes troublesome or persistent, contact a clinician for evaluation and possible management strategies.
Rare but more serious reactions can occur, such as severe allergic reactions or skin reactions. Seek urgent medical help if symptoms such as widespread rash, blistering, swelling of the face or lips, or breathing difficulty develop. Uncommon liver-related symptoms such as yellowing of the skin or eyes, dark urine, or upper abdominal pain should also be reported promptly.
Note that this list does not include every possible adverse effect. If there are concerns about any symptom while taking Provigil, a healthcare professional should be consulted. The information provided by a pharmacist or prescriber should be reviewed in the context of the official product label.
Medication interactions may alter how Provigil works or raise the chance of side effects. A comprehensive review of all medicines, including over-the-counter products and herbal supplements, is recommended before starting treatment. Some interactions may require dose adjustments or avoidance of certain substances.
Contraceptive effects can be impacted by modafinil in some individuals; additional non-hormonal or alternative contraception methods may be advised during treatment. If a hormonal contraceptive is being used, discuss potential interactions with a clinician or pharmacist.
Enzyme inducers or inhibitors can influence modafinil levels in the body. Any new prescription should be discussed with a pharmacist to determine whether monitoring or dose changes are needed. Alcohol consumption should generally be limited, and the effects of alcohol on wakefulness and blood pressure should be considered during therapy.
It is important to report any new medications started during Provigil treatment. If a patient develops a fever, rash, or signs of infection, contact a healthcare professional to determine whether a change in therapy is required. For uncertain interactions, check the official leaflet or consult a pharmacist for Ireland-specific guidance.
The safety of Provigil during pregnancy has not been established in all populations. If pregnancy is considered or confirmed, the potential benefits and risks should be discussed with a healthcare professional. Alternatives may be explored if indicated.
Breastfeeding while taking Provigil is not routinely recommended unless a clinician determines that the benefits outweigh potential risks to the infant. If breastfeeding occurs during treatment, a healthcare professional should provide guidance on timing and safety. Decisions will take into account infant exposure and the mother's clinical need for wakefulness therapy.
In all situations, the health care professional will assess the suitability of Provigil during pregnancy or lactation and may suggest monitoring or an alternative regimen. If pregnancy is planned, a discussion with a clinician is advised to plan a safe course of action.
Readers are advised to consult the official leaflet for pregnancy and breastfeeding information and to seek personalised guidance from a healthcare professional in Ireland before continuing or starting treatment if pregnancy or breastfeeding is a consideration.
The need for a prescription for Provigil depends on local regulations. In Ireland, a prescription may be required. A pharmacist can confirm the current rule and provide guidance on access through a licensed clinician. Do not obtain Provigil without proper medical oversight.
Improvements in daytime wakefulness are often reported within days to a few weeks of starting treatment, though response can vary between individuals. If no meaningful benefit is observed after an appropriate trial period, a clinician should reassess the treatment plan. Further evaluation may be warranted to optimise therapy.
If a dose is missed, it should be skipped and regular dosing resumed at the next scheduled time. Do not double the dose to compensate for a missed one. If there is concern about daytime sleepiness, consult a clinician for tailored guidance.
Provigil can be taken with or without food. Food does not usually negate its overall effect, but large meals close to dosing time may influence absorption slightly. Alcohol should be used with caution, as it can affect sleep and daytime alertness.
The duration of treatment is determined by a clinician based on the condition, response to therapy, and any side effects. Some patients may require long-term use with regular monitoring, while others might alternate therapies or discontinue after improvement. Regular medical review is advised.
Urgent medical advice should be sought if there are signs of severe allergic reaction or a serious skin reaction, chest pain, severe headache with neurological symptoms, confusion, or any new/ worsening psychiatric symptoms. Seek prompt help if there is any indication of liver problems, such as yellowing of the skin or eyes, dark urine, or persistent abdominal pain.
Long-term use should be regularly reviewed by a clinician. As with any medication, risks and benefits should be weighed over time. If ongoing wakefulness therapy is needed, monitoring for side effects, interactions, and changes in health status is recommended. A healthcare professional can determine whether continued use remains appropriate.
Aging can influence the response to wakefulness-promoting medicines. Dosing and monitoring may differ for older adults, and care is taken to minimise adverse effects. A clinician should individualise treatment based on overall health and concomitant therapies.
Potential interactions may alter effectiveness or increase side effects. A full medication review, including over-the-counter and herbal products, is essential before starting Provigil. Any new medicines should prompt a clinician to reassess therapy and safety.
The official patient information leaflet and local healthcare professionals provide authoritative guidance for Provigil use. If there is any uncertainty, contact a pharmacist or doctor for tailored advice within the Irish healthcare framework.
Additional information is available through the official patient information leaflet supplied with Provigil. This leaflet includes precise details on indications, dosing, contraindications, and precautions. It is important to read it alongside advice from a pharmacist or doctor.
Healthcare professionals, including pharmacists, can offer personalised explanations about Provigil, its role in sleep disorder management, and how it interacts with other treatments. In Ireland, contact a community pharmacist or a general practitioner for guidance tailored to the specific health needs and regulatory requirements.
When questions arise about treatment, it is prudent to seek clarification from the prescriber or pharmacist. If necessary, a referral to a sleep specialist or another appropriate clinician may be considered for comprehensive assessment and management of the sleep disorder. Documentation of all medications and health conditions supports safe, informed decision-making.
Access to high-quality information supports safe use of Provigil. Always ensure that the information comes from legitimate sources and that healthcare professionals review any changes in therapy. For accurate, up-to-date guidance, rely on the official leaflet and professional advice.
14–21 days. Free from €182.27 .
5–9 days. €27.34
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
